Objective To explore clinical values of ischemia modified albumin(IMA) in early diagnosis of ischemic stroke(IS). Methods 86 cases of IS patients were divided into 5 groups according to the time of IS onset 3h, 6h, 12h, 24h and 48h group. The serum IMA levels in IS patients and 20 health controls were tested by using albumin cobalt binding test. Results The concentration of IMA in 20 healthy controls was 75±8.6U/ml. IS onset 3h later, IMA increased significantly to 99.1±11.7 U/mL. Whiles 48h later, the serum IMA concentration was reduced to 87.3±26.5 U/mL. The IMA concentration of IS patients in group of 3 h, 12 h and 24 h were significant higher than that of healthy controls, the P values were 0.004, 0.049 and 0.002 respectively. Conclusion The ischemia modified albumin is useful biochemical marker for early diagnosis of ischemic stroke.
LI Fen-e
,
KANG Xi-xiong
. Clinical Application of Ischemia-modified Albumin inDiagnosis of Ischemic Stroke[J]. Labeled Immunoassays and Clinical Medicine, 2013
, 20(3)
: 137
-139
.
DOI: 10.11748/bjmy.issn.1006-1703.2013.03.004
[1] Bar-Or D, Lau E, Winkler J V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report[J]. Emerg Med, 2000, 19: 311-315.
[2] Abboud H, Labreuche J, Meseguer E, et al. Ischemia-modified albumin in acute stroke[J]. Cerebrovasc Dis, 2007, 23(2-3):216-220.
[3] Han K, Jia N, Yang L, et al. Correlation between ischemia-modified albumin and lipid levels in patients with acute cer ebrovascular disease[J]. Mol Med Rep, 2012, 6(3):621-624.
[4] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J]. 中华神经科杂志, 2010. 43(2): 146-153.